Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109712952 | 10971295 | 2 | F | 201501 | 20160715 | 20150331 | 20160729 | EXP | BR-AMGEN-BRASP2015029338 | AMGEN | 51.00 | YR | A | F | Y | 74.00000 | KG | 20160729 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109712952 | 10971295 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, 1X/WEEK | U | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 109712952 | 10971295 | 2 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | 75 MG, DAILY | 0 | 75 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, DAILY | 0 | 20 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 4 | C | HYDROCHOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 1 | 25 MG, DAILY | 0 | 25 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 5 | C | ARAVA | LEFLUNOMIDE | 1 | 20 MG, DAILY | 0 | 20 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 6 | C | AAS | ASPIRIN | 1 | 200 MG, DAILY | 0 | 200 | MG | |||||||||
| 109712952 | 10971295 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, DAILY | 0 | 100 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, DAILY | 0 | 100 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 9 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 100 MG, DAILY | 0 | 100 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 10 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 75 MG, DAILY | 0 | 75 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 11 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG, DAILY | 0 | 40 | MG | TABLET | ||||||||
| 109712952 | 10971295 | 12 | C | LOSARTAN. | LOSARTAN | 1 | 50 MG, DAILY | 0 | 50 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109712952 | 10971295 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109712952 | 10971295 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109712952 | 10971295 | Abdominal pain | |
| 109712952 | 10971295 | Abdominal pain upper | |
| 109712952 | 10971295 | Abdominal rigidity | |
| 109712952 | 10971295 | Diabetes mellitus | |
| 109712952 | 10971295 | Glucose urine present | |
| 109712952 | 10971295 | Infection | |
| 109712952 | 10971295 | Injection site erythema | |
| 109712952 | 10971295 | Injection site hypersensitivity | |
| 109712952 | 10971295 | Injection site pruritus | |
| 109712952 | 10971295 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109712952 | 10971295 | 1 | 201412 | 0 | ||
| 109712952 | 10971295 | 3 | 2005 | 0 | ||
| 109712952 | 10971295 | 4 | 2010 | 0 | ||
| 109712952 | 10971295 | 5 | 2013 | 0 | ||
| 109712952 | 10971295 | 6 | 2010 | 0 | ||
| 109712952 | 10971295 | 7 | 2011 | 0 | ||
| 109712952 | 10971295 | 8 | 2012 | 0 | ||
| 109712952 | 10971295 | 9 | 2011 | 0 | ||
| 109712952 | 10971295 | 10 | 2010 | 0 | ||
| 109712952 | 10971295 | 11 | 2010 | 0 | ||
| 109712952 | 10971295 | 12 | 2009 | 0 |